Original StudiesPremenstrual Syndrome (PMS) in Adolescents: Severity and Impairment
Introduction
Premenstrual syndrome (PMS) is a constellation of physical, mood and behavioral symptoms that are limited to the luteal phase, cause problems for the woman, and are not better explained by another diagnosis.1 It is a commonly accepted belief in medicine that adolescents suffer from dysmenorrhea, but that PMS is unusual in this young age group.2, 3, 4 Few studies have distinguished between PMS and dysmenorrhea in adolescents, and there continues to be scant information on adolescent PMS in the literature. These limitations and the continuing lack of differentiation between dysmenorrhea and PMS in young women may compromise effective treatment for these disorders.
The few reported studies of PMS in adolescents contradict the prevailing belief that PMS is neither distressing or common. An earlier study that assessed premenstrual symptoms in adolescents who were attending a health service (mean age 17.6 years) found that the most common mood and behavioral symptoms were impaired social function, depressive changes and autonomic physical changes. These reports were nearly identical to those of adult women who responded to the same Premenstrual Assessment Form (PAF).5 Another study of mothers and daughters likewise found that symptoms and symptom severity as assessed by the PAF did not differ between adolescents and adults, although the adolescents experienced more symptoms during the menstrual phase, due in part to dysmenorrhea.6 In a survey of high school adolescents (ages 14–18), 85% reported premenstrual symptoms, although 48% were mild, 27% were moderate, and only 11% were severe. Only one girl had obtained medical treatment for these symptoms.7 A recent report described three cases of adolescents diagnosed with premenstrual dysphoric disorder (PMDD), a severe form of PMS, and found that fluoxetine treatment led to a complete resolution of the symptoms.8
The objectives of the present study were to determine the presence of PMS in patients at an adolescent gynecology practice, and assess the severity of the reported symptoms and the extent to which the symptoms impaired functioning.
Section snippets
Subject Selection
Patients attending a primary-care adolescent gynecology practice during a 6-month period in 2004 were asked by their physician to complete a brief symptom questionnaire during an office visit. Approximately half the patient visits in the practice were contraceptive care or “well-patient” visits. Adolescents with no serious medical problems were the potential participants in the study. Other inclusion criteria were ages 13 to 18 years with regular menstrual periods in normal range (22–35 days).
Results
The mean age of the 94 participants was 16.5 years (±1.3 SD). Eighty-three percent were Caucasian, with the remainder African American (2%) or other/not reported (15%). In response to the questionnaire items, the mean duration that the teens had experienced PMS was 1.9 years (±2.2 SD). The mean age at menarche was 12.5 years (±1.7 SD), with a mean time from menarche to experiencing PMS symptoms of 1.9 years (±1.9 SD). Sixty-seven percent of the teens reported a family member with PMS.
Discussion
These findings indicate that although nearly two thirds of the teens said they had PMS when asked in a questionnaire, only 31% met the criteria for moderate to severe PMS when the reported severity, impairment, and timing of the symptoms were taken into consideration. These data show the importance of determining the severity of the symptoms and their relationship to the menstrual cycle, as numerous studies have shown.4 The results also challenge the belief that PMS is unusual in teenagers,
References (16)
- et al.
Fluctuations in symptoms and moods during the menstrual cycle
J Psychosom Res
(1969) - et al.
Premenstrual symptoms in adolescents
J Adolesc Health Care
(1989) - et al.
Firstborn adolescent daughters and mothers with and without premenstrual syndrome: a comparison
J Adolesc Health
(1991) - et al.
A survey of adolescent dysmenorrhea and premenstrual symptom frequency. A model program for prevention, detection, and treatment
J Adolesc Health Care
(1989) - et al.
Premenstrual dysphoric disorder in adolescents: case reports of treatment with fluoxetine and review of the literature
J Adolesc Health
(2005) - et al.
Reliability and validity of a daily diary for premenstrual syndrome
Psychiatry Res
(1996) - et al.
Premenstrual syndrome and associated symptoms in adolescent girls
Eur J Obstet Gynecol Reprod Biol
(2004) - et al.
Premenstrual symptoms: prevalence and severity in an adolescent sample
J Adolesc Health
(1998)
Cited by (70)
Experiences with Menses in Transgender and Gender Nonbinary Adolescents: Menses in Transgender and Gender Nonbinary Adolescents
2022, Journal of Pediatric and Adolescent GynecologyCitation Excerpt :Our data provide the first evidence that transgender and gender nonbinary adolescents are distressed by their periods. Their menstrual history and associated pain and other symptoms are consistent with those of the general adolescent population.23-25 However, our patients report high rates of mood symptoms related to menses and significant gender dysphoria or distress that is caused or exacerbated by their periods.
Premenstrual syndrome and premenstrual dysphoric disorder in adolescents
2022, Current Problems in Pediatric and Adolescent Health CareAdvancement of yogurt production technology
2022, Advances in Dairy Microbial ProductsAssociation of Premenstrual Dysphoric Disorder and Eating Behaviors Among Nursing Students: A Cross-Sectional Study
2021, Journal of Pediatric and Adolescent GynecologyMenstrual Characteristics and Related Problems in 9- to 18-Year-Old Turkish School Girls
2018, Journal of Pediatric and Adolescent GynecologyVitamin D Supplementation for Premenstrual Syndrome-Related Mood Disorders in Adolescents with Severe Hypovitaminosis D
2016, Journal of Pediatric and Adolescent GynecologyCitation Excerpt :The questionnaire addressed the most prevalent symptoms of the emotional and cognitive domains (anxiety, irritability, sadness, crying easily, and disturbed relationships). All participants were encouraged to rate the intensity of their symptoms using a scale ranging from none (for a score of 0) to mild (for a score of 1), moderate (for a score of 2), severe (for a score of 3), and extremely severe (for a score of 4).20–24 Only patients reporting symptoms of intensity from severe to extremely severe for the period examined were subsequently enrolled in the study.
Presented in part at the annual meeting of the North American Society for Pediatric and Adolescent Gynecology, New Orleans, LA, May 2005.